FDA approves first biological product derived from transgenic animal.
Lavine
Greg
G
D000818:Animals; D030801:Animals, Genetically Modified; D000991:Antithrombins / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D001688:Biological Products / Q000009:adverse effects / Q000235:genetics / Q000592:standards*; D017277:Drug Approval; D006041:Goats; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000991:Antithrombins; D001688:Biological Products; D011994:Recombinant Proteins